Atypical antipsychotic (AAP)-induced metabolic toxicity : study of mechanisms, biomarkers and reversal strategies
Atypical antipsychotics are commonly prescribed for the treatment of psychiatric disorders such as schizophrenia. However, long term use of atypical antipsychotics lead to metabolic adverse effects such as weight gain, insulin resistance, and dyslipidemia, all of which are independent risk factors f...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Liverpool
2018
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.755627 |